Mahamaya Lifesciences (BOM:544611) Interest Coverage: 3.79 (As of Mar. 2026) — 14% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:544611 Mahamaya Lifesciences Ltd BOM:544611
16 GF Score
Price ₹166.45
! 4 Warning Signs
View Full Analysis

What is Mahamaya Lifesciences Interest Coverage?

Mahamaya Lifesciences BOM:544611 16 Interest Coverage is 3.79 as of Mar. 2026, which is 14% above its 10-year median of 3.33. GuruFocus rates BOM:544611 with a GF Score™ of 16/100. The stock has 4 warning signs investors should review. Among 202 Agriculture companies, Mahamaya Lifesciences ranks worse than 68.81% on this metric.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Mahamaya Lifesciences's Operating Income for the six months ended in Mar. 2026 was ₹162 Mil. Mahamaya Lifesciences's Interest Expense for the six months ended in Mar. 2026 was ₹-43 Mil. Mahamaya Lifesciences's interest coverage for the quarter that ended in Mar. 2026 was 3.79. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for Mahamaya Lifesciences's Interest Coverage or its related term are showing as below:

BOM:544611' s Interest Coverage Range Over the Past 10 Years
Min: 2.48   Med: 3.33   Max: 3.97
Current: 3.79


BOM:544611's Interest Coverage is ranked worse than
68.81% of 202 companies
in the Agriculture industry
Industry Median: 7.13 vs BOM:544611: 3.79

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Mahamaya Lifesciences  (BOM:544611) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


Mahamaya Lifesciences Interest Coverage Related Terms


Mahamaya Lifesciences Interest Coverage Historical Data

* Premium members only.

The historical data trend for Mahamaya Lifesciences's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Mahamaya Lifesciences Interest Coverage Chart

Mahamaya Lifesciences Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Interest Coverage
3.97 3.25 2.48 3.33 3.84

Mahamaya Lifesciences Semi-Annual Data
Mar22 Mar23 Mar24 Sep24 Mar25 Mar26
Interest Coverage Get a 7-Day Free Trial N/A N/A 4.45 2.50 3.79

BOM:544611 vs CTVA, CF, MOS: Interest Coverage Comparison

For the Agricultural Inputs subindustry, Mahamaya Lifesciences's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mahamaya Lifesciences Interest Coverage vs Agriculture Industry

For the Agriculture industry and Basic Materials sector, Mahamaya Lifesciences's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Mahamaya Lifesciences's Interest Coverage falls into.


BOM:544611
16GF Score
Mahamaya Lifesciences Ltd BOM:544611
Interest Coverage is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mahamaya Lifesciences Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Mahamaya Lifesciences's Interest Coverage for the fiscal year that ended in Mar. 2026 is calculated as

Here, for the fiscal year that ended in Mar. 2026, Mahamaya Lifesciences's Interest Expense was ₹-81 Mil. Its Operating Income was ₹313 Mil. And its Long-Term Debt & Capital Lease Obligation was ₹36 Mil.

Interest Coverage=-1* Operating Income (A: Mar. 2026 )/Interest Expense (A: Mar. 2026 )
=-1*312.704/-81.387
=3.84

Mahamaya Lifesciences's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Here, for the six months ended in Mar. 2026, Mahamaya Lifesciences's Interest Expense was ₹-43 Mil. Its Operating Income was ₹162 Mil. And its Long-Term Debt & Capital Lease Obligation was ₹36 Mil.

Interest Coverage=-1* Operating Income (Q: Mar. 2026 )/Interest Expense (Q: Mar. 2026 )
=-1*162.376/-42.884
=3.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.

Frequently Asked Questions Learn more about Interest Coverage →
What does a Interest Coverage of 3.79 mean?
Mahamaya Lifesciences (BOM:544611) has a Interest Coverage of 3.79 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Mahamaya Lifesciences and its competitors. This is 14% above median its historical median of 3.33. Over the past decade, Mahamaya Lifesciences' Interest Coverage has ranged from 2.48 to 3.97. According to the industry distribution chart, Mahamaya Lifesciences ranks #139 out of 202 companies in the Agriculture industry, placing it in the top 68.8%.
Is Mahamaya Lifesciences' Interest Coverage too high?
Mahamaya Lifesciences' current Interest Coverage of 3.79 is 14% above median its 10-year median of 3.33. Over the past 10 years, this metric has ranged from a low of 2.48 to a high of 3.97. The Agriculture industry median Interest Coverage is 7.13. Mahamaya Lifesciences' value of 3.79 is 46.8% below this industry median. Based on the distribution chart, Mahamaya Lifesciences ranks #139 out of 202 companies in the Agriculture industry, which is below the industry midpoint. Overall, Mahamaya Lifesciences has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Mahamaya Lifesciences' Interest Coverage compare to CTVA and CF?
According to the Agriculture industry distribution chart, Mahamaya Lifesciences ranks #139 out of 202 companies for Interest Coverage. This places Mahamaya Lifesciences in the lower half of its industry. The industry median Interest Coverage is 7.13. Mahamaya Lifesciences' value of 3.79 is 46.8% below this benchmark. Historically, Mahamaya Lifesciences' own Interest Coverage has ranged from 2.48 to 3.97 over the past decade. While the company's 10-year median is 3.33 vs. the industry median of 7.13, Mahamaya Lifesciences has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for an Agriculture company?
The median Interest Coverage among Agriculture companies is 7.13, based on 202 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mahamaya Lifesciences's current Interest Coverage of 3.79 is 46.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Mahamaya Lifesciences and its competitors. For the Agriculture industry, the median Interest Coverage is 7.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mahamaya Lifesciences's current Interest Coverage is 3.79, which is 14% above median its own 10-year median of 3.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mahamaya Lifesciences stock overvalued right now?
Mahamaya Lifesciences (BOM:544611) has a current Interest Coverage of 3.79. The current Interest Coverage is 3.79, which is 14% above median its 10-year median of 3.33 and 46.8% below the Agriculture industry median of 7.13. Mahamaya Lifesciences' overall GF Score™ is 16/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Mahamaya Lifesciences (BOM:544611), the current Interest Coverage is 3.79 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Mahamaya Lifesciences Business Description

Address Sohna Road, Sector-49, Unit No. 369, 370, 370A & 370B, 3rd Floor, Prime Tower-B1, Spaze ITech Park, Gurugram, HR, IND, 122018
Mahamaya Lifesciences Ltd specializes in the manufacturing of pesticide formulations and supplies bulk formulations catering to both Indian agrochemical companies as well as multinational corporations (MNCs). The company's offerings include Insecticides, Herbicides, and Fungicides. Geographically, it serves multiple Indian states including Punjab, Haryana, Rajasthan, and Uttar Pradesh, and internationally serves countries like the Dominican Republic, Turkey, Egypt, and the UAE. The company generates revenue from the sale of its pesticide formulations.
16GF Score

Get the complete analysis for BOM:544611

Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹166.45
Price